Συγγραφείς:
Kotsianidis, I.
Papageorgiou, S.G.
Pappa, V.
Galanopoulos, A.G.
Viniou, N.-A.
Vassilakopoulos, T.P.
Papoutselis, M.
Vrachiolias, G.
Papadopoulos, V.
Diamantopoulos, P.T.
Tsokanas, D.
Kourakli, A.
Symeonidis, A.
Λέξεις-κλειδιά:
antianemic agent; azacitidine; granulocyte colony stimulating factor, acute myeloid leukemia; adult; aged; allogeneic stem cell transplantation; Article; bone marrow suppression; bone marrow toxicity; cancer prognosis; cohort analysis; controlled study; cytogenetics; disease exacerbation; disease registry; drug dose reduction; drug efficacy; drug hypersensitivity; drug withdrawal; female; follow up; French Prognostic Scoring System; genetic risk; high risk patient; human; International Prognostic Scoring System; low risk patient; major clinical study; male; multiple cycle treatment; myelodysplastic syndrome; overall survival; prognostic assessment; retrospective study; survival rate; survival time; treatment outcome; treatment response; World Health Organization classification based Prognostic Scoring System
